Clinical Trials in Australia

Panel: Clinical Trials in Australia – the Outlet to International Markets
Moderator: Brendan Flynn, Deputy Executive Chair Melbourne Biomedical Precinct
Mike Watson, Senior Director of Business Development, Nucleus Network
Steven Roan, BD Manager, Novotech
Blair Lucas, CEO, CoSec Consulting
Nadia Nahmany, VP Operations, Bioforum Australia

With over 40% cashback for clinical trials, facilities for preclinical and Phase 1, 2 and 3 trials, no Investigational New Drug (IND) requirement and ethics approval in an average of 6 weeks, saving 6 to 9 months, Australia sets a premier location for clinical trials, building on a strong foundation of talent, world-class infrastructure and a vibrant culture of collaboration. Nucleus Network, Novotech, CoSec Consulting and Bioforum Data Focused CRO offer a one-stop shop for Sponsors conducting clinical trials. Join us for a lively discussion to learn more on how your company can benefit from the many opporutnities to jumpstart and accelerate your outlet to commercialization worldwide!